Literature DB >> 29057501

Different approaches to heart valve decellularization: A comprehensive overview of the past 30 years.

Filippo Naso1, Alessandro Gandaglia1.   

Abstract

Xenogeneic decellularized heart valve scaffolds have the potential to overcome the limitations of existing bioprosthetic heart valves that have limited duration due to calcification and tissue degeneration phenomena. This article presents a review of 30 years of decellularization approaches adopted in cardiovascular tissue engineering, with a focus on the use, either individually or in combination, of different detergents. The safety and efficacy of cell-removal procedures are specifically reported and discussed, as well as the structure and biomechanics of the treated extracellular matrix (ECM). Detergent residues within the ECM, production of hyaluronan fragments, safe removal of cellular debris, and the persistence of the alpha-Gal epitope after the decellularization treatments are of particular interest as parameters for the identification of the best tissue for the manufacture of bioprostheses. Special attention has also been given to key factors that should be considered in the manufacture of the next generation of xenogeneic bioprostheses, where tissues must retain the ability to be remodeled and to grow in weight along with body reshaping.
© 2017 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  alphaGal; cellular debris; decellularization; detergent residues; heart valve

Mesh:

Substances:

Year:  2017        PMID: 29057501     DOI: 10.1111/xen.12354

Source DB:  PubMed          Journal:  Xenotransplantation        ISSN: 0908-665X            Impact factor:   3.907


  9 in total

1.  Liver scaffolds obtained by decellularization: A transplant perspective in liver bioengineering.

Authors:  Marlon Lemos Dias; Bruno Andrade Paranhos; Regina Coeli Dos Santos Goldenberg
Journal:  J Tissue Eng       Date:  2022-06-20       Impact factor: 7.940

Review 2.  Engineering Efforts to Refine Compatibility and Duration of Aortic Valve Replacements: An Overview of Previous Expectations and New Promises.

Authors:  Stefano Rizzi; Sara Ragazzini; Maurizio Pesce
Journal:  Front Cardiovasc Med       Date:  2022-04-18

3.  Generation of cattle knockout for galactose-α1,3-galactose and N-glycolylneuraminic acid antigens.

Authors:  Andrea Perota; Irina Lagutina; Roberto Duchi; Elisa Zanfrini; Giovanna Lazzari; Jean Paul Judor; Sophie Conchon; Jean Marie Bach; Tomaso Bottio; Gino Gerosa; Cristina Costa; Manuel Galiñanes; Jean Christian Roussel; Vered Padler-Karavani; Emanuele Cozzi; Jean Paul Soulillou; Cesare Galli
Journal:  Xenotransplantation       Date:  2019-05-22       Impact factor: 3.907

4.  Biodegradable Poly-ε-Caprolactone Scaffolds with ECFCs and iMSCs for Tissue-Engineered Heart Valves.

Authors:  Georg Lutter; Thomas Puehler; Lukas Cyganek; Jette Seiler; Anita Rogler; Tanja Herberth; Philipp Knueppel; Stanislav N Gorb; Janarthanan Sathananthan; Stephanie Sellers; Oliver J Müller; Derk Frank; Irma Haben
Journal:  Int J Mol Sci       Date:  2022-01-04       Impact factor: 5.923

Review 5.  Can Heart Valve Decellularization Be Standardized? A Review of the Parameters Used for the Quality Control of Decellularization Processes.

Authors:  F Naso; A Gandaglia
Journal:  Front Bioeng Biotechnol       Date:  2022-02-17

Review 6.  Biomaterials for Regenerative Medicine in Italy: Brief State of the Art of the Principal Research Centers.

Authors:  Francesca Camponogara; Federica Zanotti; Martina Trentini; Elena Tiengo; Ilaria Zanolla; Elham Pishavar; Elisa Soliani; Marco Scatto; Paolo Gargiulo; Ylenia Zambito; Stefano De Luca; Letizia Ferroni; Barbara Zavan
Journal:  Int J Mol Sci       Date:  2022-07-26       Impact factor: 6.208

Review 7.  Current development of bovine jugular vein conduit for right ventricular outflow tract reconstruction.

Authors:  Chenggang Li; Bo Xie; Ruizhe Tan; Lijin Liang; Zhaoxiang Peng; Qi Chen
Journal:  Front Bioeng Biotechnol       Date:  2022-08-04

8.  Decellularized bovine jugular vein and hand-sewn ePTFE valved conduit for right ventricular outflow tract reconstruction in children undergoing Ross procedure.

Authors:  Haoyong Yuan; Ting Lu; Zhongshi Wu; Yifeng Yang; Jinlan Chen; Qin Wu; Sijie Wu; Hong Zhang; Tao Qian; Can Huang
Journal:  Front Cardiovasc Med       Date:  2022-09-07

Review 9.  Residual Bioprosthetic Valve Immunogenicity: Forgotten, Not Lost.

Authors:  Paul Human; Deon Bezuidenhout; Elena Aikawa; Peter Zilla
Journal:  Front Cardiovasc Med       Date:  2022-01-04
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.